Nature Communications

B7-H3-mediated cis-inhibition of EGFR by a tumor-selective bispecific antibody enhances anti-tumor efficacy and minimizes toxicities

2026-02-24

Full text

DOI https://doi.org/10.1038/s41467-026-69703-7